Mishka Terplan, M.D., M.P.H., FACOG, DFASAM
Mishka Terplan, M.D., M.P.H., FACOG, DFASAM
Medical Director/Senior Research Scientist
M.D., University of California, San Francisco
M.P.H., University of North Carolina, Chapel Hill
mterplan@friendsresearch.org
Phone: 410-837-3977 ext. 240
Fax: 410-752-4218
Medical Director/Senior Research Scientist
M.D., University of California, San Francisco
M.P.H., University of North Carolina, Chapel Hill
mterplan@friendsresearch.org
Phone: 410-837-3977 ext. 240
Fax: 410-752-4218
Brief Biography
Selected Publications
Dr. Mishka Terplan is board certified in both obstetrics and gynecology and in addiction medicine. His primary clinical, research, public health, and advocacy interests lie along the intersections of reproductive and behavioral health.
Dr. Terplan has published extensively on health inequities, discrimination, and access to treatment and is internationally recognized as an expert in the care of pregnant and parenting people with substance use disorder. He has been central to guidance document development at the American Congress of Obstetrician Gynecologists (ACOG), the American Society of Addiction Medicine (ASAM) and the Substance Abuse and Mental Health Services Administration (SAMHSA) and has participated in expert panels at Center for Disease Control, Office of the National Drug Control Policy, Office of Women’s Health, US Food and Drug Administration, the National Institutes of Health, and the United Nations Office on Drugs and Crime primarily on issues related to gender, reproduction, and addiction.
In addition to his work for FRI, he is adjunct faculty at the University of California, San Francisco where he is a Substance Use Warmline clinician for the National Clinician Consultation Center.
Board, A., Vivolo-Kantor, A., Kim, S. Y., Tran, E. L., Thomas, S. A., Terplan, M., Smid, M. C., Sanjuan, P. M., Wright, T., Davidson, A., Wachman, E. M., Rood, K. M., Morse, D., Chu, E., & Miele, K. (2025). Using ICD Codes Alone May Misclassify Overdoses Among Perinatal People.
American journal of preventive medicine, 68,
(3), 563–570. https://doi.org/10.1016/j.amepre.2024.12.001
Choi, S., Knopf, E., Kim, E., Neighbors, C. J., Berry, C. A., Hade, E., Trinh-Shevrin, C., Terplan, M., Seligman, N. S., Garry, D. J., & McNeely, J. (2025). A multi-level explanatory-sequential mixed-methods study of perinatal toxicology practices in New York State: Protocol.
PloS one, 20,
(12), e0339284. https://doi.org/10.1371/journal.pone.0339284
Cioffi, C. C., Acevedo, A. M., Cohen, D. J., Kaufman, M. R., Parker, K., Terplan, M., & Lindner, S. R. (2025). A cross-sectional study of differences in medication for opioid use disorder receipt among pregnant people enrolled in Medicaid in Oregon, United States.
Addiction (Abingdon, England), 120,
(5), 997–1006. https://doi.org/10.1111/add.16752
Grace Lin, C. W., Bateman, B. T., Straub, L., Hernández-Díaz, S., Vine, S. M., Jones, H. E., Connery, H. S., Davis, J. M., Gray, K. J., Lester, B., Suarez, E. A., Sujan, A. C., Terplan, M., & Huybrechts, K. F. (2025). Buprenorphine and Methadone Discontinuation During Pregnancy and the Postpartum Period: A Nationwide Cohort Study.
The American journal of psychiatry,
appiajp20241127. Advance online publication. https://doi.org/10.1176/appi.ajp.20241127
Habersham, L. L., Townsel, C., Terplan, M., & Hurd, Y. L. (2025). Substance use and use disorders during pregnancy and the postpartum period.
American journal of obstetrics and gynecology, 232,
(4), 337–353.e1. https://doi.org/10.1016/j.ajog.2025.01.007
Habersham, L. L., Woolfolk, C. L., Taylor, K. J., Terplan, M., & Mark, K. (2025). Factors Associated with Positive Toxicology at Delivery: Insights From the University of Maryland Medical System.
Maternal and child health journal,
10.1007/s10995-025-04107-5. Advance online publication. https://doi.org/10.1007/s10995-025-04107-5
Kobernik, E. K., DeSisto, C. L., Welder, L. E., DePadilla, L., Levecke, M., Terplan, M., & Ko, J. Y. (2025). Suicide Attempts Among Women Ages 18-55 Years with Opioid Use: National Addictions Vigilance Intervention and Prevention Program 2018-2020.
Journal of women's health (2002),
10.1089/jwh.2024.0837. Advance online publication. https://doi.org/10.1089/jwh.2024.0837
Kramer, B. E., Warren, N., Terplan, M., Creanga, A. A., & Bower, K. M. (2025). Managing Bias in the Care of Pregnant and Parenting People with Substance Use Disorder.
Journal of midwifery & women's health,
10.1111/jmwh.13744. Advance online publication. https://doi.org/10.1111/jmwh.13744
Lim, G., Carvalho, B., George, R. B., Bateman, B. T., Brummett, C. M., Ip, V. H. Y., Landau, R., Osmundson, S., Raymond, B., Richebe, P., Soens, M., & Terplan, M. (2025). Consensus statement on pain management for pregnant patients with opioid use disorder from the Society for Obstetric Anesthesia and Perinatology, Society for Maternal-Fetal Medicine, and American Society of Regional Anesthesia and Pain Medicine.
American journal of obstetrics and gynecology,
S0002-9378(24)01183-9. Advance online publication. https://doi.org/10.1016/j.ajog.2024.12.006
Martin, C. E., Bello, J. K., Galati, B. M., Buss, J. L., Terplan, M., Jones, H. E., Mitchell, K. T., Martins, S. S., Grucza, R. A., Suarez, E. A., & Xu, K. Y. (2025). Discontinuation of treatment for alcohol use disorder during pregnancy and postpartum in the United States.
Alcohol, clinical & experimental research, 49,
(9), 1972–1982. https://doi.org/10.1111/acer.70117
Nidey, N., McAllister, J. M., Terplan, M., & Kair, L. R. (2025). Breastfeeding and Developmental Outcomes in Infants with Prenatal Cannabis Exposure: A Retrospective Cohort Study.
Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine,
10.1177/15568253251409805. Advance online publication. https://doi.org/10.1177/15568253251409805
Nidey, N., Raff, E., Ferdous Khan, M. T., Watkins, S. L., McAllister, J. M. J., Kair, L., Terplan, M., & Greiner, A. (2025). The Impact of Frequency of Cannabis Use on Hypertensive Disorders During Pregnancy.
Journal of addiction medicine,,
10.1097/ADM.0000000000001454. Advance online publication. https://doi.org/10.1097/ADM.0000000000001454
Park, J., Terplan, M., & Ratner, J. (2025). Hospital Care for Pregnant Persons With OUD Review.
American journal of medicine open, 14,
100117. https://doi.org/10.1016/j.ajmo.2025.100117
Parsaei, M., Rashidian, P., Parsaei, A., Terplan, M., Tarafdari, A., Masrour, M., Beikmarzehei, A., Hassani, P., Motevaselian, M., & Sanjari Moghaddam, H. (2025). Impact of prenatal tobacco exposure on brain structure and function in offspring: a systematic review and meta-analysis of MRI findings.
Neuroradiology,,
10.1007/s00234-025-03696-w. Advance online publication. https://doi.org/10.1007/s00234-025-03696-w
Poehlmann, J., Johnson, E. I., Ossorio, P. N., Highsmith, K., Harden, B. J., Terplan, M., Sanjuan, P. M., McKelvey, L., Coles, C. D., Chaiyachati, B. H., Walker, H. P., Shlafer, R., Pritzl, K., Krishnan, C. A., Averill, S., Das, S., Torres-Gomez, S., Hilliard, F., Gannon, B., & Thompson, W. K. (2025). Retaining infants and young children who experience transitions in care in longitudinal studies of child health and development: Considerations from the HEALthy Brain and Child Development study.
Infant mental health journal, 47,
(1), e70057. https://doi.org/10.1002/imhj.70057
Roberts, S. C. M., Gould, H., Terplan, M., & Biggs, M. A. (2025). Beliefs about reporting self-managed abortion to government authorities among health professionals registering for a professional education webinar.
Contraception,
111325. Advance online publication. https://doi.org/10.1016/j.contraception.2025.111325
Roberts, S. C. M., Liu, G., & Terplan, M. (2025). Medications for Alcohol Use Disorder Among Birthing People With an Alcohol-related Diagnosis.
Journal of addiction medicine, 19,
(1), 41–46. https://doi.org/10.1097/ADM.0000000000001372
Schauberger, C. W., Smid, M. C., Terplan, M., & Wright, T. E. (2025). Lessons from Maternal Mortality Reviews. How Addiction Care Providers can help improve Outcomes for Pregnant, Postpartum, and Parenting people.
Substance use & misuse, 60,
(3), 446–451. https://doi.org/10.1080/10826084.2024.2422957
Sieger, M. L., Godoy, L., Moore, T. E., Nichols, C., Goldsborough, E. J., Chen, S., Terplan, M., Griffin, B. A., & Patrick, S. W. (2025). Connecticut’s Novel Prenatal Substance Exposure Policy Is Associated With Declining CPS Reports And Foster Placements.
Health affairs (Project Hope), 44,
(7), 821–829. https://doi.org/10.1377/hlthaff.2024.01160
Terplan, M., O’Grady, K. E., Monico, L. B., Schwartz, R. P., Gryczynski, J., Fishman, M. J., & Mitchell, S. G. (2025). Adverse Events at 1 Month Following Medication Initiation for Opioid Use Disorder Among Adolescents and Young Adults.
Substance use & addiction journal, 46,
(1), 72–77. https://doi.org/10.1177/29767342241275738
Thomas, S. A., Board, A., Pabst, L., Dorsey, A., Deputy, N. P., Terplan, M., Kariisa, M., Chen, M. H., Wachman, E. M., Wright, T. G., Smid, M., O’Connor, T. G., Sanjuan, P. M., Ko, H., Seligman, N. S., Shakib, J. H., Benninger, K. L., Rood, K. M., Chaphalkar, C., Henninger, M. L., … Kim, S. Y. (2025). Neonatal Abstinence Syndrome in the MATernaL and Infant clinical NetworK.
Hospital pediatrics,
e2025008543. Advance online publication. https://doi.org/10.1542/hpeds.2025-008543
Tran, E. L., Dorsey, A. N., Miele, K., Gilboa, S. M., Gosdin, L., Terplan, M., Sanjuan, P. M., Seligman, N. S., Wright, T., Wachman, E. M., Smid, M., Henninger, M., Leeman, L., Schneider, P. D., Rood, K., Louis, J. M., Caveglia, S., Davidson, A., Shakib, J., Shrestha, H., … Kim, S. Y. (2025). Patterns of Medication for Opioid Use Disorder During Pregnancy, 7 Clinical Sites, MATernaL and Infant clinical NetworK (MAT-LINK), 2014-2021.
Journal of addiction medicine, 19,
(2), 208–215. https://doi.org/10.1097/ADM.0000000000001426
Ukoha, E. P., & Terplan, M. (2025). Treatment and decriminalization of the mother-infant dyad in perinatal opioid use disorder.
Seminars in perinatology, 49,
(1), 152005. https://doi.org/10.1016/j.semperi.2024.152005
Witcraft, S. M., Johnson, E., Eitel, A. E., Moreland, A. D., King, C., Terplan, M., & Guille, C. (2025). Listening to Black Pregnant and Postpartum People: Using Technology to Enhance Equity in Screening and Treatment of Perinatal Mental Health and Substance Use Disorders.
Journal of racial and ethnic health disparities, 12,
(3), 1574–1586. https://doi.org/10.1007/s40615-024-01989-z
Xu, J. H., DeFranco, E. A., Murnan, A. W., Terplan, M., Merhar, S. L., & Nidey, N. L. (2025). Experiences of healthcare discrimination and treatment outcomes among pregnant and postpartum people with opioid use disorder.
Journal of substance use and addiction treatment, 174,,
209707. https://doi.org/10.1016/j.josat.2025.209707
Xu, J. H., Merhar, S. L., Defranco, E. A., McAllister, J. M., Terplan, M., & Nidey, N. L. (2025). (2025). Maternal Perception of Infant Sleep and Bonding in Opioid Use Disorder.
Journal of addiction medicine, 19,
(1), 83–88. https://doi.org/10.1097/ADM.0000000000001381
Xu, K. Y., Jones, H. E., Martin, C. E., Smid, M. C., Tiako, M. J. N., Terplan, M., & Krans, E. E. (2025). Perinatal Substance Use-Related Content at Major Addiction Scientific Conferences: An Analysis of Oral Presentation Sessions.
Journal of addiction medicine,
10.1097/ADM.0000000000001438. Advance online publication. https://doi.org/10.1097/ADM.0000000000001438
Alexander K., Roberts, S.C.M, Terplan, M. (2024). We’re checking a box and, you know, covering our own”: health professionals’ descriptions of hospital-policy making regarding child welfare reporting related to birthing people’s drug use.
Substance Use & Addiction Journal,
doi: 10.1177/29767342241273416. Epub ahead of print. PMID: 39323361.
Board, A., D’Angelo, D. V., Miele, K., Asher, A., Salvesen von Essen, B., Denny, C. H., Terplan, M., Dunkley, J., & Kim, S. Y. (2024). Naloxone Use During Pregnancy-Data from 26 US Jurisdictions, 2019-2020.
Journal of addiction medicine,
10.1097/ADM.0000000000001337. Advance online publication. https://doi.org/10.1097/ADM.0000000000001337
Ceasar, R. C., Terplan, M., & Rewegan, A. (2024). Cannabis Use and Perinatal Health.
JAMA, 331,
(3), 256–257. https://doi.org/10.1001/jama.2023.23236
Jilani, S. M., Davis, J. M., Goldstein, D., Grossman, M., Jansson, L. M., Terplan, M., & Jones, H. E. (2024). Clinically defining the opioid-exposed birthing person and infant as a dyad to support bedside care, surveillance, and research.
Frontiers in pediatrics, 12,
1349102. https://doi.org/10.3389/fped.2024.1349102
Jilani, S. M., Davis, J. M., Grossman, M., Jones, H. E., Terplan, M., & Jansson, L. M. (2024). A Dyadic Framework of Care for Opioid-exposed Birthing Persons and Their Infants and Children.
The Journal of pediatrics, 266,,
113893. https://doi.org/10.1016/j.jpeds.2023.113893
Jones, C., Ford, B. R., Shearer, R. D., Terplan, M., Stewart, K., & Winkelman, T. N. A. (2024). Perinatal substance use treatment and criminal legal system referral trends.
Journal of substance use and addiction treatment, 166,
209492. https://doi.org/10.1016/j.josat.2024.209492
King, C., Laynor, G., McNeely, J., Fawole, A., Lee, M., Terplan, M., & Choi, S. (2024). Strategies to improve delivery of equitable and evidence-informed care for pregnant and birthing people with a substance use disorder in acute care settings: A scoping review protocol.
PloS one, 19,
(3), e0300183. https://doi.org/10.1371/journal.pone.0300183
Landis, R. K., Stein, B. D., Dick, A. W., Griffin, B. A., Saloner, B. K., Terplan, M., & Faherty, L. J. (2024). Trends and Disparities in Perinatal Opioid Use Disorder Treatment in Medicaid, 2007-2012.
Medical care research and review : MCRR, 81,
(2), 145–155. https://doi.org/10.1177/10775587231216515
Lim, G., Carvalho, B., George, R. B., Bateman, B. T., Brummett, C. M., Ip, V. H. Y., Landau, R., Osmundson, S. S., Raymond, B., Richebe, P., Soens, M., & Terplan, M. (2024). Consensus Statement on Pain Management for Pregnant Patients with Opioid-Use Disorder from the Society for Obstetric Anesthesia and Perinatology, Society for Maternal-Fetal Medicine, and American Society of Regional Anesthesia and Pain Medicine.
Anesthesia and analgesia,,
10.1213/ANE.0000000000007237. Advance online publication. https://doi.org/10.1213/ANE.0000000000007237
McNamara, K. A., Murnion, B., Fotheringham, P., Terplan, M., Lintzeris, N., Oei, J. L., Bond, D. M., Nassar, N., & Black, K. I. (2024). Interconnections between unintended pregnancy, alcohol and other drug use, and pregnancy, birth, infant, childhood and socioeconomic outcomes: a scoping review.
BMJ sexual & reproductive health,,
bmjsrh-2023-202140. Advance online publication. https://doi.org/10.1136/bmjsrh-2023-202140
Minozzi, S., Ambrosi, L., Saulle, R., Uhm, S. S., Terplan, M., Sinclair, J. M., & Agabio, R (2024). Psychosocial and medication interventions to stop or reduce alcohol consumption during pregnancy.
The Cochrane database of systematic reviews, 4,
(4), CD015042. https://doi.org/10.1002/14651858.CD015042.pub2
Ratner, J. A., Kirschner, J. H., Spencer, B., & Terplan, M (2024). Services for perinatal patients with opioid use disorder: a comprehensive Baltimore City-wide 2023 assessment.
Addiction science & clinical practice, 19,
(1), 73. https://doi.org/10.1186/s13722-024-00507-0
Reddy, J., Schiff, D., Terplan, M., Jones, H., & Putnam-Hornstein, E. (2024). Child Protection System Removal and Short-Interval Births Among Individuals With Prenatal Substance Use.
Obstetrics and gynecology, 143,
(5), 700–703. https://doi.org/10.1097/AOG.0000000000005552
Roberts, S. C. M, Liu, G., & Terplan, M. (2024). Medications for Alcohol Use Disorder among Birthing People with an Alcohol-related Diagnosis.
Journal of addiction medicine,,
10.1097/ADM.0000000000001372. Advance online publication. https://doi.org/10.1097/ADM.0000000000001372
Straub, L., Bateman, B. T., Hernández-Díaz, S., Zhu, Y., Suarez, E. A., Vine, S. M., Jones, H. E., Connery, H. S., Davis, J. M., Gray, K. J., Lester, B., Terplan, M., Zakoul, H., Mogun, H., & Huybrechts, K. F. (2024). Comparative Safety of In Utero Exposure to Buprenorphine Combined With Naloxone vs Buprenorphine Alone.
JAMA, 332,
(10), 805–816. https://doi.org/10.1001/jama.2024.11501
Suarez, E. A., Bateman, B. T., Straub, L., Hernández-Díaz, S., Jones, H. E., Gray, K. J., Connery, H. S., Davis, J. M., Lester, B., Terplan, M., Zhu, Y., Vine, S. M., Mogun, H., & Huybrechts, K. F. (2024). First Trimester Use of Buprenorphine or Methadone and the Risk of Congenital Malformations.
JAMA internal medicine, 184,
(3), 242–251. https://doi.org/10.1001/jamainternmed.2023.6986
Terplan, M., O’Grady, K. E., Monico, L. B., Schwartz, R. P., Gryczynski, J., Fishman, M. J., & Mitchell, S. G. (2024). Adverse Events at 1 Month Following Medication Initiation for Opioid Use Disorder Among Adolescents and Young Adults.
Substance use & addiction journal,
29767342241275738. Advance online publication. https://doi.org/10.1177/29767342241275738
Ukoha, E. P., & Terplan, M. (2024). Treatment and decriminalization of the mother-infant dyad in perinatal opioid use disorder.
Seminars in perinatology,
152005. Advance online publication. https://doi.org/10.1016/j.semperi.2024.152005
Witcraft, S. M., Johnson, E., Eitel, A. E., Moreland, A. D., King, C., Terplan, M., & Guille, C. (2024). Listening to Black Pregnant and Postpartum People: Using Technology to Enhance Equity in Screening and Treatment of Perinatal Mental Health and Substance Use Disorders.
Journal of racial and ethnic health disparities,
10.1007/s40615-024-01989-z. Advance online publication. https://doi.org/10.1007/s40615-024-01989-z
Xu, J. H., Merhar, S. L., Defranco, E. A., McAllister, J. M., Terplan, M., & Nidey, N. L. (2024). Maternal Perception of Infant Sleep and Bonding in Opioid Use Disorder.
Journal of addiction medicine,,
10.1097/ADM.0000000000001381. Advance online publication. https://doi.org/10.1097/ADM.0000000000001381
Zaugg, C., Terplan, M., Mailman, K., & Roberts, S. C. M. (2024). Reasons pregnant people use cannabis to self-treat health conditions during pregnancy: Results from a US population-based survey.
Drug and alcohol review,
10.1111/dar.13934. Advance online publication. https://doi.org/10.1111/dar.13934
Alexander K. and Terplan, M. (2023). Contingency Management
: Promises, Gaps, and Philosophical Limitations. The American Journal of Accountable Care (AJAC),11(2):28-29. https://doi.org/10.37765/ajac.2023.89382
Alexander K., Sanjuan, P., Terplan, M. (2023). How has ecological momentary assessment been used with people in medication-based treatment for opioid use disorder? Current Addiction Reports.
https://doi.org/10.1007/s40429-023-00492-5
Barber, C. M., & Terplan, M. (2023). Principles of care for pregnant and parenting people with substance use disorder: the obstetrician gynecologist perspective.
Front Pediatr, 11,
1045745. https://doi.org/10.3389/fped.2023.1045745
Cohen, S., Nielsen, T., Chou, J. H., Hoeppner, B., Koenigs, K. J., Bernstein, S. N., Smith, N. A., Perlman, N., Sarathy, L., Wilens, T., Terplan, M., & Schiff, D. M. (2023). Disparities in Maternal-Infant Drug Testing, Social Work Assessment, and Custody at 5 Hospitals.
Acad Pediatr, 23,
(6), 1268-1275. https://doi.org/10.1016/j.acap.2023.01.012
Darlington, C. K., Clark, R., Jacoby, S. F., Terplan, M., Alexander, K., & Compton, P. (2023). Outcomes and experiences after child custody loss among mothers who use drugs: A mixed studies systematic review.
Drug Alcohol Depend, 251,
110944. https://doi.org/10.1016/j.drugalcdep.2023.110944
DeSisto, C. L., Terplan, M., Kacha-Ochana, A., Green, J. L., Mueller, T., Cox, S., & Ko, J. Y. (2023). Buprenorphine use and setting type among reproductive-aged women self-reporting nonmedical prescription opioid use.
J Subst Use Addict Treat,,
209083. https://doi.org/10.1016/j.josat.2023.209083
Edwards, F., Roberts, S. C. M., Kenny, K. S., Raz, M., Lichtenstein, M., & Terplan, M. (2023). Medical Professional Reports and Child Welfare System Infant Investigations: An Analysis of National Child Abuse and Neglect Data System Data.
Health Equity, 7,
(1), 653-662. https://doi.org/10.1089/heq.2023.0136
Jarlenski, M., Shroff, J., Terplan, M., Roberts, S. C. M., Brown-Podgorski, B., & Krans, E. E. (2023). Association of Race With Urine Toxicology Testing Among Pregnant Patients During Labor and Delivery.
JAMA Health Forum, 4,
(4), e230441. https://doi.org/10.1001/jamahealthforum.2023.0441
Kelty, E., Terplan, M., Orr, C., & Preen, D. B. (2023). Neonatal Outcomes Associated With in Utero Exposure to Oxycodone, Overall and by Trimester of Exposure: A Retrospective Cohort Study.
J Pain, 24,
(4), 617-626. https://doi.org/10.1016/j.jpain.2022.11.007
Landis, R. K., Stein, B. D., Griffin, B. A., Saloner, B. K., Terplan, M., & Faherty, L. J. (2023). Disparities in Perinatal and Emergency Care Receipt Among Women With Perinatal Opioid Use Disorder in Medicaid, 2007 to 2012.
J Addict Med.,
https://doi.org/10.1097/ADM.0000000000001199
Lipsett, M., Wyant-Stein, K., Mendes, S., Berger, E., Berkman, E. T., Terplan, M., & Cioffi, C. C. (2023). Addressing stigma within the dissemination of research products to improve quality of care for pregnant and parenting people affected by substance use disorder.
Front Psychiatry, 14,
1199661. https://doi.org/10.3389/fpsyt.2023.1199661
Mazel, S., Alexander, K., Cioffi, C., & Terplan, M. (2023). Interventions to Support Engagement in Addiction Care Postpartum: Principles and Pitfalls.
Subst Abuse Rehabil, 14,
49-59. https://doi.org/10.2147/sar.S375652
Monico, L.B., O’Grady, K.E., Gryczynski, J., Garrison, K., Ross, T., Terplan, M., & Mitchell, S.G. (2023). Substance Use and Mental Health Responses to COVID-19 Among Rural Adolescents.
Arch Pediatr,
8: 274. https://doi.org/10.29011/2575-825X.100274
Sarathy, L., Chou, J. H., Lerou, P. H., Terplan, M., Mark, K., Dorfman, S., Wilens, T. E., Bernstein, S. N., & Schiff, D. M. (2023). Limited Utility of Toxicology Testing at Delivery for Perinatal Cannabis Use.
Hospital Pediatrics, 13,
(4), 317-325. https://doi.org/10.1542/hpeds.2022-006897
Siegel, M. R., Cohen, S. J., Koenigs, K., Woods, G. T., Schwartz, L. N., Sarathy, L., Chou, J. H., Terplan, M., Wilens, T., Ecker, J. L., Bernstein, S. N., & Schiff, D. M. (2023). Assessing the clinical utility of toxicology testing in the peripartum period.
Am J Obstet Gynecol MFM, 5,
(7), 100963. https://doi.org/10.1016/j.ajogmf.2023.100963
Stoltman, J. J. K., Marra, A., Uppercue, K., & Terplan, M. (2023). Reporting on addiction: countering misinformation about addiction, harm reduction, treatment, and recovery.
J Am Pharm Assoc (2003), 63,
(1), 230-233. https://doi.org/10.1016/j.japh.2022.09.010
Sufrin, C., Kramer, C., Terplan, M., Fiscella, K., Olson, S., Voegtline, K., & Latkin, C. (2023). Availability of Medications for Opioid Use Disorder in U.S. Jails.
J Gen Intern Med, 38,
(6), 1573-1575. https://doi.org/10.1007/s11606-022-07812-x
Temkin, S. M., & Terplan, M. (2023). Levels of Gynecologic Care: A Task Force Consensus Statement.
Obstet Gynecol, 142,
(4), 993-994. https://doi.org/10.1097/AOG.0000000000005363
Terplan, M. (2023). Asleep at the wheel: leadership in obstetrics and gynecology.
Am J Obstet Gynecol,
https://doi.org/10.1016/j.ajog.2023.08.005
Terplan, M. (2023). Urine Drug Screening for Isolated Marijuana Use in Labor and Delivery Units.
Obstet Gynecol, 141,
(3), 620. https://doi.org/10.1097/aog.0000000000005090
West, B. S., Choi, S., & Terplan, M. (2023). In our responses to the overdose epidemic, we cannot forget pregnant and postpartum people.
Int J Drug Policy, 120,
104153.
Work, E. C., Muftu, S., MacMillan, K. D. L., Gray, J. R., Bell, N., Terplan, M., Jones, H. E., Reddy, J., Wilens, T. E., Greenfield, S. F., Bernstein, J., & Schiff, D. M. (2023). Prescribed and Penalized: The Detrimental Impact of Mandated Reporting for Prenatal Utilization of Medication for Opioid Use Disorder.
. Matern Child Health J,
1-9. https://doi.org/10.1007/s10995-023-03672-x
Zaugg, C., Terplan, M., & Roberts, S. C. M. (2023). Clinician views on reporting pregnant and birthing patients who use alcohol and/or drugs to child welfare.
Am J Obstet Gynecol MFM,,
5(10), 101109. https://doi.org/10.1016/j.ajogmf.2023.101109
Agabio, R., Sinclair, J., Terplan, M., Traccis, F., & Minozzi, S. (2022). Psychosocial and medication interventions to stop or reduce alcohol consumption during pregnancy.
The Cochrane Database of Systematic Reviews, 4.,
https://doi.org/https://doi.org/10.1002/14651858.CD015042
Hochstatter KR., Terplan, M., Mitchell, S. G., Schwartz, R. P., Dusek, K., Wireman, K., & Gryczynski, J. (2022). Characteristics and correlates of fentanyl preferences among people with opioid use disorder.
Drug and Alcohol Dependence, 240,
109630. Doi: 10.1016/j.drugalcdep.2022.109630
Jilani, S. M., Jones, H. E., Grossman, M., Jansson, L. M., Terplan, M., Faherty, L. J., Khodyakov, D., Patrick, S. W., & Davis, J. M. (2022). Standardizing the clinical definition of opioid withdrawal in the neonate.
Journal of Pediatrics, 243,
33-39.e31. Doi: 10.1016/j.jpeds.2021.12.021
Jilani, S. M., Jones, H. E., Jansson, L. M., Terplan, M., & Davis, J. M. (2022). Reply.
Journal of Pediatrics, 246,
283-284. Doi: 10.1016/j.jpeds.2022.04.022
Kelty, E., Terplan, M., Orr, C., & Preen, D. B. (2022). Neonatal outcomes associated with in utero exposure to oxycodone, overall and by trimester of exposure: A retrospective cohort study.
The Journal of Pain.,
Doi: 10.1016/j.jpain.2022.11.007
Koenigs, K. J., Chou, J. H., Cohen, S., Nolan, M., Liu, G., Terplan, M., Cummings, B. M., Nielsen, T., Smith, N. A., Distefano, J., Bernstein, S. N., & Schiff, D. M. (2022). Informed consent is poorly documented when obtaining toxicology testing at delivery in a Massachusetts cohort.
American Journal of Obstetrics & Gynecology MFM, 4,
(4), 100621. Doi: 10.1016/j.ajogmf.2022.100621
Lim, G., Soens, M., Wanaselja, A., Chyan, A., Carvalho, B., Landau, R., George, R. B., Klem, M. L., Osmundson, S. S., Krans, E. E., Terplan, M., & Bateman, B. T. (2022). A systematic scoping review of peridelivery pain management for pregnant people with opioid use disorder: From the Society for Obstetric Anesthesia and Perinatology and Society for Maternal Fetal Medicine.
Anesthesia and Analgesia, 135,
(5), 912-925. Doi: 10.1213/ane.0000000000006167
Marques, P. X., Wand, H., Nandy, M., Tan, C., Shou, H., Terplan, M., Mark, K., Brotman, R. M., Wilson, D. P., Ravel, J., Hsia, R. C., & Bavoil, P. M. (2022). Serum antibodies to surface proteins of Chlamydia trachomatis as candidate biomarkers of disease: results from the Baltimore Chlamydia Adolescent/Young Adult Reproductive Management (CHARM) cohort.
FEMS microbes,
3. https://doi.org/https://doi.org/10.1093/femsmc/xtac004
Martin, C. E., Parlier-Ahmad, A. B., Beck, L., Jain, V., & Terplan, M. (2022). A comparison of sex-specific reproductive and sexual health needs between addiction medicine and primary care treatment settings.
Substance Use and Misuse, 57,
(8), 1229-1236. Doi: 10.1080/10826084.2022.2076873
Martin, C. E., Parlier-Ahmad, A. B., Beck, L., Scialli, A., & Terplan, M. (2022). Need for and receipt of substance use disorder treatment among adults, by gender, in the United States.
Public Health Reports, 137,
(5), 955-963. Doi: 10.1177/00333549211041554
Mitchell, S. G., Monico, L. B., Gryczynski, J., Ross, T., Terplan, M., & O’Grady, K. E. (2022). Examining the Effectiveness of the FaCES Adolescent SBIRT Intervention.
J Adolesc Health, 71,
(4s), S41-s48. https://doi.org/10.1016/j.jadohealth.2022.04.013
Nidey, N., Hoyt-Austin, A., Chen, M. J., Bentley, B., Tabb, K. M., Anyigbo, C., Wilder, C., Terplan, M., McAllister, J. M., Wexelblatt, S. L., Murnan, A., & Kair, L. R. (2022). Racial inequities in breastfeeding counseling among pregnant people who use cannabis.
Obstetrics and Gynecology, 140,
(5), 878-881. Doi: 10.1097/aog.0000000000004834
Schiff, D. M., Stoltman, J. J. K., Nielsen, T. C., Myers, S., Nolan, M., Terplan, M., Patrick, S. W., Wilens, T. E., & Kelly, J. (2022). Assessing stigma towards substance use in pregnancy: A randomized study testing the impact of stigmatizing language and type of opioid use on attitudes toward mothers with opioid use disorder.
Journal of Addiction Medicine, 16,
(1), 77-83. Doi: 10.1097/adm.0000000000000832
Schiff, D. M., Work, E. C., Muftu, S., Partridge, S., MacMillan, K. D. L., Gray, J. R., Hoeppner, B. B., Kelly, J. F., Greenfield, S. F., Jones, H. E., Wilens, T. E., Terplan, M., & Bernstein, J. (2022). “You have to take this medication, but then you get punished for taking it:” Lack of agency, choice, and fear of medications to treat opioid use disorder across the perinatal period.
Journal of Substance Abuse Treatment, 139,
, 108765. Doi: 10.1016/j.jsat.2022.108765
Smid, M. C., & Terplan, M. (2022). What obstetrician-gynecologists should know about substance use disorders in the perinatal period.
Obstetrics and Gynecology, 139,
(2), 317-337. Doi: 10.1097/aog.0000000000004657
Stoltman, J. J. K., Lander, L. R., Patrick, J. H., Terplan, M., & Jones, H. E. (2022). Interest in co-located reproductive and sexual health services among women and men receiving medication for opioid use disorder in an outpatient treatment clinic.
Front Psychiatry, 13,
910389. Doi: 10.3389/fpsyt.2022.910389
Stoltman, J. J. K., Marra, A., Uppercue, K., & Terplan, M. ( (2022). Reporting on Addiction: An Innovative, Collaborative Approach to Reduce Stigma by Improving Media Coverage and Public Messaging about Addiction Treatment and Recovery.
Drug and Alcohol Dependence, 241,
109648. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2022.109648
Suarez, E. A., Huybrechts, K. F., Straub, L., Hernández-Díaz, S., Jones, H. E., Connery, H. S., Davis, J. M., Gray, K. J., Lester, B., Terplan, M., Mogun, H., & Bateman, B. T. (2022). Buprenorphine versus methadone for opioid use disorder in pregnancy.
The New England Journal of Medicine, 387,
(22), 2033-2044. Doi: 10.1056/NEJMoa2203318
Sufrin, C., Kramer, C. T., Terplan, M., Fiscella, K., Olson, S., Voegtline, K., & Latkin, C. (2022b). Availability of medications for the treatment of opioid use disorder among pregnant and postpartum individuals in US Jails.
JAMA Network Open, 5,
(1), e2144369. doi: 10.1001/jamanetworkopen.2021.44369
Sufrin, C., Kramer, C., Terplan, M., Fiscella, K., Olson, S., Voegtline, K., & Latkin, C. (2022a). Availability of medications for opioid use disorder in US Jails.
Journal of General Internal Medicine,
Doi: 10.1007/s11606-022-07812-x
Terplan, M. (2022a). Prenatal nicotine or cannabis exposure and offspring neurobehavioral outcomes.
Obstetrics and Gynecology, 139,
(5), 939. doi: 10.1097/aog.0000000000004779
Terplan, M. (2022b). Test or talk: Empiric bias and epistemic injustice.
Obstetrics and Gynecology, 140,
(2), 150-152. doi: 10.1097/aog.0000000000004884
Woodhams, E., Samura, T., White, K., Patton, E., & Terplan, M (2022). Society of family planning clinical recommendations: Contraception and abortion care for persons who use substances.
Contraception, 112,
2-10. doi: 10.1016/j.contraception.2022.05.010
Young-Wolff, K. C., Slama, N. E., Sarovar, V., Terplan, M., Ansley, D., Adams, S. R., & Alexeeff, S. E. (2022). Trends in self-reported and biochemically verified cocaine and methamphetamine use among pregnant individuals in Northern California, 2011-2019.
JAMA Network Open, 5,
(12), e2248055. doi: 10.1001/jamanetworkopen.2022.48055
Young-Wolff, K. C., Slama, N., Sarovar, V., Conway, A., Tucker, L. Y., Goler, N., Terplan, M., Ansley, D., Adams, S. R., & Armstrong, M. A. (2022). Association of pregnancy intentions with substance use during early pregnancy.
Journal of Addiction Medicine, 16,
(1), 118-121. doi: 10.1097/adm.0000000000000825
Admon, L. K., Terplan, M., & Winkelman, T. N. A. (2021). A closer look at health Inequities among pregnant people with unstable housing.
JAMA Network Open, 4,
(4), e217855.
Bachireddy, C., & Terplan, M. (2021). Payer strategies to ensure access to care for individuals with opioid use disorder during COVID-19.
American Journal of Managed Care, 27,
(3), 91-92.
Jilani, S. M., Jones, H. E., Grossman, M., Jansson, L. M., Terplan, M., Faherty, L. J., Khodyakov, D., Patrick, S. W., & Davis, J. M. (2021). Standardizing the clinical definition of opioid withdrawal in the neonate.
Journal of Pediatrics,
Kelty, E., Terplan, M., Greenland, M., & Preen, D. (2021). Pharmacotherapies for the treatment of alcohol use disorders during pregnancy: Time to reconsider?
Drugs, 81(7),
739-748.
Mark, K., Pace, L., Temkin, S. M., Crimmins, S., & Terplan, M. (2021). Concordance and discordance between maternal and newborn drug test results.
American Journal of Obstetrics & Gynecology MFM, 3,
(4), 100366.
Martin, C. E., Parlier-Ahmad, A. B., Beck, L., Scialli, A., & Terplan, M. (2021). Need for and receipt of substance use disorder treatment among adults, by gender, in the United States.
Public Health Reports,
333549211041554.
McCarthy, J. J., Jones, H. E., Terplan, M., Rudolf, V. P., & von Klimo, M. C. (2021). Changing outdated methadone regulations that harm pregnant patients.
Journal of Addiction Medicine, 15,
(2), 93-95.
Parlier-Ahmad, A. B., Terplan, M., Svikis, D. S., Ellis, L., & Martin, C. E. (2021). Recovery capital among people receiving treatment for opioid use disorder with buprenorphine.
Harm Reduction Journal, 18,
(1), 103.
Patel, E., Bandara, S., Saloner, B., Stuart, E. A., Goodman, D., Terplan, M., McCourt, A., White, S., & McGinty, E. E. (2021). Heterogeneity in prenatal substance use screening despite universal screening recommendations: Findings from the Pregnancy Risk Assessment Monitoring System, 2016-2018.
American Journal of Obstetrics & Gynecology MFM, 3,
(5), 100419.
Schiff, D. M., Nielsen, T. C., Hoeppner, B. B., Terplan, M., Hadland, S. E., Bernson, D., Greenfield, S. F., Bernstein, J., Bharel, M., Reddy, J., Taveras, E. M., Kelly, J. F., & Wilens, T. E. (2021). Methadone and buprenorphine discontinuation among postpartum women with opioid use disorder.
American Journal of Obstetrics & Gynecology, 225,
(4), 424.e421-424.e412.
Schiff, D. M., Stoltman, J. J. K., Nielsen, T. C., Myers, S., Nolan, M., Terplan, M., Patrick, S. W., Wilens, T. E., & Kelly, J. (2021). Assessing stigma towards substance use in pregnancy: A randomized study testing the impact of stigmatizing language and type of opioid use on attitudes toward mothers with opioid use disorder.
Journal of Addiction Medicine,
Shadowen, C., Wheeler, R., & Terplan, M. (2021). Patient and provider knowledge of and attitudes toward medical conditions and medication during pregnancy.
Addiction Science & Clinical Practice, 16,
(1), 22.
Temkin, S. M., & Terplan, M. (2021). Contributions, aspirations, and challenges of academic specialist divisions in obstetrics and gynecology.
Obstetrics & Gynecology,
137(2), 374-375.
Terplan, M. (2021). Substance use and use disorder in pregnancy and postpartum.
International Review of Pscyhiatry, 33,
(6), 501.
Terplan, M., van Dis, J., & Temkin, S. M. (2021). Reengineering academic departments of obstetrics and gynecology to operate in a pandemic world and beyond: A joint American Gynecological and Obstetrical Society and Council of University Chairs of Obstetrics and Gynecology statement.
American Journal of Obstetrics & Gynecology,,
224(1), 129-130.
Young-Wolff, K. C., Slama, N., Sarovar, V., Conway, A., Tucker, L. Y., Goler, N., Terplan, M., Ansley, D., Adams, S. R., & Armstrong, M. A. (2021). Association of pregnancy intentions with substance use during early pregnancy.
Journal of Addiction Medicine.,